|
Volumn 2006, Issue 337, 2006, Pages
|
HIFing the brakes: therapeutic opportunities for treatment of human malignancies.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARNT PROTEIN, HUMAN;
BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
HIF1A PROTEIN, HUMAN;
HIF1A PROTEIN, MOUSE;
HIF3A PROTEIN, HUMAN;
HIF3A PROTEIN, MOUSE;
HYPOXIA INDUCIBLE FACTOR 1ALPHA;
HYPOXIA INDUCIBLE FACTOR 1BETA;
HYPOXIA INDUCIBLE FACTOR 2, ALPHA SUBUNIT;
HYPOXIA-INDUCIBLE FACTOR 2, ALPHA SUBUNIT;
MOP2 PROTEIN, HUMAN;
TRANSCRIPTION FACTOR;
TRANSFORMING GROWTH FACTOR ALPHA;
TUMOR PROTEIN;
VASCULOTROPIN A;
VON HIPPEL LINDAU PROTEIN;
ANIMAL;
BIOSYNTHESIS;
CELL DIVISION;
DISEASE COURSE;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
METABOLISM;
MOUSE;
MOUSE MUTANT;
NEOPLASM;
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
TRANSGENIC MOUSE;
VON HIPPEL LINDAU DISEASE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;
BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS;
CARCINOMA, RENAL CELL;
CELL DIVISION;
DISEASE PROGRESSION;
DRUG DESIGN;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HIPPEL-LINDAU DISEASE;
HUMANS;
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;
KIDNEY NEOPLASMS;
MICE;
MICE, KNOCKOUT;
MICE, TRANSGENIC;
NEOPLASM PROTEINS;
NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SIGNAL TRANSDUCTION;
TRANSCRIPTION FACTORS;
TRANSFORMING GROWTH FACTOR ALPHA;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;
|
EID: 33745328509
PISSN: None
EISSN: 15258882
Source Type: Journal
DOI: 10.1126/stke.3372006pe25 Document Type: Review |
Times cited : (34)
|
References (33)
|